Are Blood Tests for Alzheimer Disease Ready for Prime Time?

Stephen Salloway¹, Christopher Rowe^{2

3

4}, Jeffrey M Burns⁵

Affiliations

¹ Departments of Psychiatry and Neurology, Warren Alpert Medical School, Brown University, Providence, Rhode Island.
² Department of Molecular Imaging, Austin Health, Melbourne, Australia.
³ Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.
⁴ Australian Dementia Network, University of Melbourne, Melbourne, Australia.
⁵ Alzheimer's Disease Research Center, University of Kansas Medical Center, Lawrence.

Editorial

Stephen Salloway et al. JAMA. 2024.

. 2024 Oct 15;332(15):1240-1241.

doi: 10.1001/jama.2024.12814.

Stephen Salloway¹, Christopher Rowe^{2

3

4}, Jeffrey M Burns⁵

¹ Departments of Psychiatry and Neurology, Warren Alpert Medical School, Brown University, Providence, Rhode Island.
² Department of Molecular Imaging, Austin Health, Melbourne, Australia.
³ Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.
⁴ Australian Dementia Network, University of Melbourne, Melbourne, Australia.
⁵ Alzheimer's Disease Research Center, University of Kansas Medical Center, Lawrence.

No abstract available

Comment on

Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia.
Lu Y, Pike JR, Chen J, Walker KA, Sullivan KJ, Thyagarajan B, Mielke MM, Lutsey PL, Knopman D, Gottesman RF, Sharrett AR, Coresh J, Mosley TH, Palta P. Lu Y, et al. JAMA. 2024 Oct 15;332(15):1258-1269. doi: 10.1001/jama.2024.6619. JAMA. 2024. PMID: 39068543 Free PMC article.
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.
Palmqvist S, Tideman P, Mattsson-Carlgren N, Schindler SE, Smith R, Ossenkoppele R, Calling S, West T, Monane M, Verghese PB, Braunstein JB, Blennow K, Janelidze S, Stomrud E, Salvadó G, Hansson O. Palmqvist S, et al. JAMA. 2024 Oct 15;332(15):1245-1257. doi: 10.1001/jama.2024.13855. JAMA. 2024. PMID: 39068545 Free PMC article.